Nestmedic lands US$285K shareholder loan, worth around $300K
What's the deal? Warsaw-based medical technology company NestmedicDealroom has a profile for this one. Try Dealroom → has secured a shareholder loan of up to US$285K (roughly $300,000) from 5HT Fundacja Rodzinna. An initial tranche of US$75K has already been disbursed, with the remaining funds available in parts under the agreed terms.
How it works: The loan can be repaid in cash, with interest set at WIBOR 3M plus 2 percentage points, by December 31, 2027. Alternatively, the investor can convert the debt by subscribing for newly issued Nestmedic shares.
What's the endgame? The flexible structure gives Nestmedic financing to support its operations while potentially strengthening its equity base. It also deepens ties with 5HT Fundacja Rodzinna, an existing shareholder. Nestmedic, listed on the Polish market, focuses on innovative solutions for patient care.
The signal: A convertible shareholder loan lets a small listed company raise cash without immediately diluting equity, keeping options open until repayment falls due. With a market cap of about US$7.69M, the arrangement points to continued backing from investors already close to the business.
Read more: tipranks.com
Image credit: Generated with Gemini
